Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page
…is living every day of your life expecting disappointment. Honestly though, Pops is a slick talker and all, but if he were a TBM he would have been put on a PIP like 4 years ago.
Stock price is such a disappointment. Our leadership touts their successes and raves about revenues, yet all we see is an ongoing price drop. This is what we get for having an in-bred BOD continuing to support Pops. ENOUGH IS ENOUGH!